Skip to main navigation Skip to search Skip to main content

Biofabrication Directions in Recapitulating the Immune System‐on‐a‐Chip

Research output: Contribution to journalReview articlepeer-review

Abstract

Ever since the implementation of microfluidics in the biomedical field, in vitro models have experienced unprecedented progress that has led to a new generation of highly complex miniaturized cell culture platforms, known as Organs-on-a-Chip (OoC). These devices aim to emulate biologically relevant environments, encompassing perfusion and other mechanical and/or biochemical stimuli, to recapitulate key physiological events. While OoCs excel in simulating diverse organ functions, the integration of the immune organs and immune cells, though recent and challenging, is pivotal for a more comprehensive representation of human physiology. This comprehensive review covers the state of the art in the intricate landscape of immune OoC models, shedding light on the pivotal role of biofabrication technologies in bridging the gap between conceptual design and physiological relevance. The multifaceted aspects of immune cell behavior, crosstalk, and immune responses that are aimed to be replicated within microfluidic environments, emphasizing the need for precise biomimicry are explored. Furthermore, the latest breakthroughs and challenges of biofabrication technologies in immune OoC platforms are described, guiding researchers toward a deeper understanding of immune physiology and the development of more accurate and human predictive models for a.o., immune-related disorders, immune development, immune programming, and immune regulation.

Original languageEnglish
Article number2304569
JournalAdvanced healthcare materials
Volume14
Issue number5
Early online date16 Apr 2024
DOIs
Publication statusPublished - 18 Feb 2025

Bibliographical note

Publisher Copyright:
© 2024 The Authors. Advanced Healthcare Materials published by Wiley-VCH GmbH.

Funding

The authors would like to thank the knowledge partners in the consortium (Wageningen UR dep. Wageningen Food & Biobased Research, Erasmus MC dep. Allergology and clinical immunology, and Utrecht University div. of Pharmacology) for their valuable scientific input. This work was funded by the Dutch Ministry of Economic Affairs program TKI\u2010AF under grant agreement LWV200123: PRedictive model For the sensitising capacity of novel nutritional pRoteins (PREFER study), and industrial partners Nutricia Research B.V., Cargill R&D Centre Europe, Arla Foods Ingredients Group P/S, Soci\u00E9t\u00E9 des Produits Nestl\u00E9 S.A., Phycom BV, The Seaweed Company B.V., and Mycorena AB and by Utrecht Institute for Pharmaceutical Sciences. The views expressed in this manuscript are those of the authors and do not necessarily reflect the position or policy of the collaborators.

FundersFunder number
Mycorena AB
Cargill R&D Centre Europe
Seaweed Company B.V.
Arla Foods Ingredients Group
Nutricia Research B.V.
S, Société des Produits Nestlé S.A.
Utrecht Institute for Pharmaceutical Sciences
Dutch Ministry of Economic Affairs program TKI‐AFLWV200123

    Keywords

    • 3D printing
    • biofabrication
    • immune cells
    • immune organs
    • immune responses
    • immune system
    • microfluidics
    • organ-on-a-chip

    Fingerprint

    Dive into the research topics of 'Biofabrication Directions in Recapitulating the Immune System‐on‐a‐Chip'. Together they form a unique fingerprint.

    Cite this